Výsledky vyhledávání - "S.C. Heslinga"

Aortic root diameter is associated with HLA-B27: identifying the patient with ankylosing spondylitis at risk for aortic valve regurgitation

Autor: Otto Kamp, Milad Baniaamam, S.C. Heslinga, T.C. Konings, Michael T. Nurmohamed, M. L. Handoko, V P van Halm, I E van der Horst-Bruinsma

Publikováno v: Rheumatology International, 42(4), 683-688. Springer Verlag
Rheumatology International, 42, 683-688
Rheumatology International, 42, 4, pp. 683-688
Baniaamam, M, Heslinga, S C, Konings, T C, Handoko, M L, Kamp, O, van Halm, V P, van der Horst-Bruinsma, I E & Nurmohamed, M T 2022, ' Aortic root diameter is associated with HLA-B27 : identifying the patient with ankylosing spondylitis at risk for aortic valve regurgitation ', Rheumatology International, vol. 42, no. 4, pp. 683-688 . https://doi.org/10.1007/s00296-021-05040-w

To assess the association between the aortic root diameter in HLA-B27 positive (+) and HLA-B27 negative (−) ankylosing spondylitis (AS) patients from the CARDAS cohort. The CARDAS study is a cross-sectional study in AS patients between 50 and 75 ye

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::926d2774582115ae4a6e1ee76aed4675
https://research.vumc.nl/en/publications/94aa9655-8f61-40b0-8983-9f93bea9580a

Zobrazit plný text záznamu

The prevalence of cardiac diseases in a contemporary large cohort of dutch elderly ankylosing spondylitis patients— the cardas study

Autor: M. Louis Handoko, Vokko P. van Halm, Milad Baniaamam, Laura Boekel, Michael T. Nurmohamed, Otto Kamp, S.C. Heslinga, T.C. Konings, Irene E. van der Horst-Bruinsma

Publikováno v: Journal of Clinical Medicine, 10(21):5069
Baniaamam, M, Heslinga, S C, Boekel, L, Konings, T C, Louis Handoko, M, Kamp, O, van Halm, V P, van der Horst-Bruinsma, I E & Nurmohamed, M T 2021, ' The prevalence of cardiac diseases in a contemporary large cohort of dutch elderly ankylosing spondylitis patients— the cardas study ', Journal of Clinical Medicine, vol. 10, no. 21, 5069 . https://doi.org/10.3390/jcm10215069
Journal of Clinical Medicine, Vol 10, Iss 5069, p 5069 (2021)
Journal of Clinical Medicine
Volume 10
Issue 21

Objectives: The aim of the present study was to determine the prevalence of specific cardiac manifestations, i.e., conduction disorders, valvular disease and diastolic left ventricular (LV) dysfunction, in a large cross-sectional controlled cohort of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4e9855568e42c05bc24978dc5975cab
https://research.vumc.nl/en/publications/cfa95a4b-9825-4b1d-b739-70bc1abe00ff

Zobrazit plný text záznamu

The effects of golimumab treatment on systolic and diastolic left ventricular function in ankylosing spondylitis

Autor: T.C. Konings, S.C. Heslinga, Hacm de Bruin-Bon, Otto Kamp, I E van der Horst-Bruinsma, Mike J L Peters, M. T. Nurmohamed, V P van Halm

Publikováno v: Biologics, 12, 143-149. Dove Medical Press Ltd.
Biologics : Targets & Therapy
Biologics: Targets and Therapy, 12, 143-149. Dove Medical Press Ltd.
Biologics: Targets & Therapy, Vol Volume 12, Pp 143-149 (2018)
Heslinga, S C, Konings, T C, van der Horst-Bruinsma, I E, Kamp, O, van Halm, V P, de Bruin-Bon, H A C M, Peters, M J & Nurmohamed, M T 2018, ' The effects of golimumab treatment on systolic and diastolic left ventricular function in ankylosing spondylitis ', Biologics: Targets and Therapy, vol. 12, pp. 143-149 . https://doi.org/10.2147/BTT.S176806

SC Heslinga,1,2 TC Konings,3 IE van der Horst-Bruinsma,1,2 O Kamp,3 VP van Halm,3,4 HACM de Bruin-Bon,4 MJ Peters,5 MT Nurmohamed1,2 1Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Reade, Amsterdam, The Netherlands; 2Depart

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11da81bd27b0303a60018910fab61c97
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85060609887&origin=inward

Zobrazit plný text záznamu

Assessment of aortic stiffness in patients with ankylosing spondylitis using cardiovascular magnetic resonance

Autor: T.C. Konings, Peter M. van de Ven, Raquel P Amier, Michael T. Nurmohamed, Christopher D. Maroules, Albert C. van Rossum, Robin Nijveldt, S.C. Heslinga, Vokko P. van Halm, Irene E. van der Horst-Bruinsma, Mike J L Peters, P. Stefan Biesbroek, Parag H. Joshi, Colby Ayers

Publikováno v: Biesbroek, P S, Heslinga, S C, van de Ven, P M, Peters, M J L, Amier, R P, Konings, T C, Maroules, C D, Ayers, C, Joshi, P H, van der Horst-Bruinsma, I E, van Halm, V P, van Rossum, A C, Nurmohamed, M T & Nijveldt, R 2018, ' Assessment of aortic stiffness in patients with ankylosing spondylitis using cardiovascular magnetic resonance ', Clinical Rheumatology, vol. 37, no. 8, pp. 2151-2159 . https://doi.org/10.1007/s10067-018-4135-x
Clinical Rheumatology, 37, 2151-2159
Clinical Rheumatology, 37(8), 2151-2159. Springer London
Clinical Rheumatology, 37, 8, pp. 2151-2159
Clinical rheumatology, 37(8), 2151-2159. Springer London

Contains fulltext : 207076.pdf (Publisher’s version ) (Closed access) To evaluate aortic stiffness in patients with ankylosing spondylitis (AS) using cardiovascular magnetic resonance (CMR) and to assess its association with AS characteristics and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0922770833aac93f482cf056249a653
https://research.vumc.nl/en/publications/2b04295b-b0c1-4b9c-900f-a7ae7f242143

Zobrazit plný text záznamu

Tumor Necrosis Factor Blocking Therapy and Congestive Heart Failure in Patients with Inflammatory Rheumatic Disorders: A Systematic Review

Autor: V P van Halm, A.M. van Sijl, S.C. Heslinga, Michael T. Nurmohamed, K. De Boer

Publikováno v: Heslinga, S C, van Sijl, A M, de Boer, K, Van Halm, V P & Nurmohamed, M 2015, ' Tumor Necrosis Factor Blocking Therapy and Congestive Heart Failure in Patients with Inflammatory Rheumatic Disorders: A Systematic Review ', Current Medicinal Chemistry, vol. 22, no. 16, pp. 1892-1902 . https://doi.org/10.2174/0929867322666150209160701
Current Medicinal Chemistry, 22(16), 1892-1902. Bentham Science Publishers B.V.

Introduction: Tumour necrosis factor (TNF) blocking therapy is an effective treatment for chronic inflammatory arthritis. As circulating TNF might induce or exacerbate the development of congestive heart failure (CHF), several trials have investigate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a55eef0dea1d027b8b399eab6ec08b9a
https://doi.org/10.2174/0929867322666150209160701

Zobrazit plný text záznamu

AB0116 Identifying the as patient at risk: is aortic root dilatation associated with HLA-B27?

Autor: I E van der Horst-Bruinsma, S.C. Heslinga, Michael T. Nurmohamed, Otto Kamp, Milad Baniaamam, T. C. Konings

Publikováno v: Abstracts Accepted for Publication.

Background Cardiac involvement is more common in Ankylosing Spondylitis (AS) patients with HLA-B27 genotype, especially aortic valvular regurgitation (AVR). AVR in AS is caused by aortic root dilatation and fibrotic thickening of the aortic cusps, bo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::11c3203864f4caa387b6e9221359d3f4
https://doi.org/10.1136/annrheumdis-2017-eular.4616

Zobrazit plný text záznamu

Diastolic left ventricular dysfunction in ankylosing spondylitis-A systematic review and meta-analysis

Autor: Carlo J. Van Dongen, Mike J L Peters, Michael T. Nurmohamed, Yvo M. Smulders, T.C. Konings, S.C. Heslinga, Irene E. van der Horst-Bruinsma

Publikováno v: Heslinga, S C, Van Dongen, C J, Konings, T C, Peters, M J, van der Horst-Bruinsma, I E, Smulders, Y M & Nurmohamed, M T 2014, ' Diastolic left ventricular dysfunction in ankylosing spondylitis-A systematic review and meta-analysis ', Seminars in Arthritis and Rheumatism, vol. 44, no. 1, pp. 14-19 . https://doi.org/10.1016/j.semarthrit.2014.02.004
Seminars in Arthritis and Rheumatism, 44(1), 14-19. W.B. Saunders Ltd

Objectives Ankylosing spondylitis (AS) is associated with increased mortality largely due to cardiovascular disease. Diastolic left ventricular (LV) dysfunction serves as a precursor to chronic heart failure and may cause morbidity and mortality. A s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b31024257f5c055e8352c5c73aa5a805
https://doi.org/10.1016/j.semarthrit.2014.02.004

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Cardiovascular risk management in patients with active Ankylosing Spondylitis: a detailed evaluation

Autor: Michael T. Nurmohamed, Inge A. M. van den Oever, Irene E. van der Horst-Bruinsma, S.C. Heslinga, Mike J L Peters, Yvo M. Smulders, Alper M. van Sijl

Publikováno v: BMC Musculoskeletal Disorders
BMC Musculoskeletal Disorders, 16:80. BioMed Central
Heslinga, S C, van den Oever, I A, van Sijl, A M, Peters, M J, van der Horst-Bruinsma, I E, Smulders, Y M & Nurmohamed, M T 2015, ' Cardiovascular risk management in patients with active Ankylosing Spondylitis: a detailed evaluation ', BMC Musculoskeletal Disorders, vol. 16, 80 . https://doi.org/10.1186/s12891-015-0532-3

Background Ankylosing spondylitis (AS) is an inflammatory disease with documented elevated cardiovascular (CV) risk due to systemic inflammation and a higher prevalence of CV risk factors. CV risk management (CV-RM) could be an effective method to re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3130ee49745363eceff6fe598ec2e155
https://doi.org/10.1186/s12891-015-0532-3

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání